The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson Disease
Open accessAbstract
IMPORTANCE: Diurnal fluctuations of motor and nonmotor symptoms and a high prevalence of sleep-wake disturbances in Parkinson disease (PD) suggest a role of the circadian system in the modulation of these symptoms. However, surprisingly little is known regarding circadian function in PD and whether circadian dysfunction is involved in the development of sleep-wake disturbances in PD. OBJECTIVE: To determine the relationship between the timing and amplitude of the 24-hour melatonin rhythm, a marker of endogenous circadian rhythmicity, with self-reported sleep quality, the severity of daytime sleepiness, and disease metrics. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study from January 1, 2009, through December 31, 2012, of 20 patients with PD receiving stable dopaminergic therapy and 15 age-matched control participants. Both groups underwent blood sampling for the measurement of serum melatonin levels at 30-minute intervals for 24 hours under modified constant routine conditions at the Parkinson's Disease and Movement Disorders Center of Northwestern University. INTERVENTIONS: Twenty-four hour monitoring of serum melatonin secretion. MAIN OUTCOMES AND MEASURES: Clinical and demographic data, self-reported measures of sleep quality (Pittsburgh Sleep Quality Index) and daytime sleepiness (Epworth Sleepiness Scale), and circadian markers of the melatonin rhythm, including the amplitude, area under the curve (AUC), and phase of the 24-hour rhythm. RESULTS: Patients with PD had blunted circadian rhythms of melatonin secretion compared with controls; the amplitude of the melatonin rhythm and the 24-hour AUC for circulating melatonin levels were significantly lower in PD patients (P < .001). Markers of the circadian phase were not significantly different between the 2 groups. Compared with PD patients without excessive daytime sleepiness, patients with excessive daytime sleepiness (Epworth Sleepiness Scale score ≥10) had a significantly lower amplitude of the melatonin rhythm and 24-hour melatonin AUC (P = .001). Disease duration, Unified Parkinson's Disease Rating Scale scores, levodopa equivalent dose, and global Pittsburgh Sleep Quality Index score in the PD group were not significantly related to measures of the melatonin circadian rhythm. CONCLUSIONS AND RELEVANCE: Circadian dysfunction may underlie excessive sleepiness in PD. The nature of this association needs to be explored further in longitudinal studies. Approaches aimed to strengthen circadian function, such as timed exposure to bright light and exercise, might serve as complementary therapies for the nonmotor manifestations of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with healthy aged people, individuals with AD or PD show considerably lower melatonin rhythm amplitudes and excessive sleepiness, as well as other sleep–wake cycle disturbances, such as later sleep onsets254–258.”
From Rhythms of life: circadian disruption and brain disorders across the lifespan (2019) · cites this paper as [258]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K., & Strohl, K. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00002 · Cited by 2,973
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Transplanted Suprachiasmatic Nucleus Determines Circadian Period
Ralph, M. R., Foster, R. G., Davis, F. C., & Menaker, M. (1990) · Science · doi:10.1126/science.2305266 · Cited by 1,853
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 389
Owen, N. E., Barker, R. A., & Voysey, Z. J. (2023) · Journal of Huntington s Disease · doi:10.3233/jhd-230567 · Cited by 13
New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson’s Disease
Kelberman, M. A., & Vazey, E. M. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0071-0 · Cited by 13
Chan, L. G., Siang, K. S. S., Yong, T. T., Chander, R. J., Tan, L., & Kandiah, N. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719892326 · Cited by 13
Sleep in Neurodegenerative Disorders
Malkani, R., & Attarian, H. (2015) · Current Sleep Medicine Reports · doi:10.1007/s40675-015-0016-x · Cited by 12
Li, Y., Ji, G. Y., Lian, M., Liu, X., Xu, Y. H., & Gui, Y. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00542-0 · Cited by 12
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review
Raheel, K., See, Q. R., Munday, V., Fakhroo, B., Ivanenko, O., Salvatelli, M. L., Mutti, C., Goadsby, P. J., Delogu, A., Naismith, S. L., et al. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01359-6 · Cited by 12
Managing sleep issues in Parkinson’s disease: an up-to-date review
Suzuki, K., Fujita, H., & Kobayashi, S. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2450789 · Cited by 13
Hadoush, H., Alqudah, A., Banihani, S. A., Al-Jarrah, M. D., Amro, A., & Aldajah, S. (2021) · Sleep Science · doi:10.5935/1984-0063.20200083 · Cited by 13
Sleepiness in neurological disorders
Dubessy, A., & Arnulf, I. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.07.005 · Cited by 12
Haeger, P. A., Bouchet, A., Ossandón, C., & Bresky, G. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.7867 · Cited by 16
Zhang, S., & Sehgal, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812536-6.00011-0 · Cited by 12
Mulak, A. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1701437 · Cited by 13
Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats
Tancheva, L. P., Lazarova, M. I., Saso, L., Kalfin, R. E., Stefanova, M. O., Uzunova, D. N., & Atanasov, A. G. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01760-z · Cited by 11
Ünal, Ö., Akgun-Unal, N., & Baltacı, A. K. (2025) · Biogerontology · doi:10.1007/s10522-025-10254-7 · Cited by 11
Pablo‐Fernández, E. D., & Warner, T. T. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00015-0 · Cited by 11
Influence of sleep disruption on protein accumulation in neurodegenerative diseases
Wang, X., Wang, R., & Li, J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.10 · Cited by 13
Zhai, Z., Xie, D., Qin, T., Zhong, Y., Xu, Y., & Sun, T. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.012 · Cited by 11
Chronotype, sleep, and sleepiness in Parkinson's disease
Murphy, S., Chibnik, L. B., & Videnović, A. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.10.011 · Cited by 11
Park, J., Han, J. W., Suh, S. W., Byun, S., Han, J. H., Bae, J. B., Kim, J. H., & Kim, K. W. (2020) · Aging · doi:10.18632/aging.102661 · Cited by 11
Jin, W., Gui, J., Li, G., Jiang, F., & Han, D. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338764 · Cited by 10
Predicting neurodegeneration from sleep related biofluid changes
Yang, Y., Kim, W. S., Michaelian, J. C., Lewis, S. J. G., Phillips, C. L., D'Rozario, A. L., Chatterjee, P., Martins, R. N., Grunstein, R. R., Halliday, G. M., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106369 · Cited by 10
Falup‐Pecurariu, C., Muntean, M., Ungureanu, L., Murășan, I., Popławska-Domaszewicz, K., Chaudhuri, К. R., & Diaconu, Ș. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2422004 · Cited by 10
Sleep–wake and circadian disturbances in Parkinson disease: a short clinical guide
Baumann, C. R. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02039-3 · Cited by 10
Högl, B. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5519 · Cited by 9
Smith, S. K., & Musiek, E. S. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.005 · Cited by 10
Circadian rhythm and neurodegenerative disorders
Werdann, M., & Zhang, Y. (2020) · Brain Science Advances · doi:10.26599/bsa.2020.9050006 · Cited by 9
Fifel, K., & Boer, T. D. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00019-4 · Cited by 10
Sleep Dysfunction in Movement Disorders: a Window to the Disease Biology
Standlee, J., & Malkani, R. G. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01220-8 · Cited by 11
Circadian Dysregulation in Mental and Physical Health
Abbott, S. M., Malkani, R. G., & Zee, P. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00039-8 · Cited by 9
Self-citationThe Central Clock in Patients With Parkinson Disease
Fifel, K., & Deboer, T. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2708 · Cited by 9
Daytime sleepiness in Parkinson's disease: a multifaceted symptom
Laudo, F. D., Baldelli, L., Mainieri, G., Loddo, G., Montini, A., Pazzaglia, C., Sala, M., Mignani, F., & Provini, F. (2023) · Frontiers in sleep · doi:10.3389/frsle.2023.1302021 · Cited by 9
Chen, D., Qian, S., Qian, W., Wu, M., Wang, X., Shen, H., Long, X., Ye, M., Gong, Y., & Chen, G. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s465898 · Cited by 8
Emerging preclinical interest concerning the role of circadian function in Parkinson’s disease
Willis, G. L., & Freelance, C. B. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.027 · Cited by 8
Hadoush, H., Lababneh, T., Banihani, S. A., Al-Jarrah, M. D., & Jamous, M. (2020) · Neurorehabilitation · doi:10.3233/nre-203075 · Cited by 8
Waheed, H., Macaulay, P. J. R., Al-Jaifi, H. A. A., Allen, K., & She, L. (2024) · Information Technology and People · doi:10.1108/itp-07-2023-0676 · Cited by 10
Melatonin Supplementation in Alzheimer’s disease: The Potential Role in Neurogenesis
Ebrahimi, R., Faramarzi, A., Salarvandian, S., Zarei, R., Heidari, M., Salehian, F., & Esmaeilpour, K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05095-x · Cited by 8
Sleep Modulates Alcohol Toxicity in Drosophila
Nobrega, A. K. D., Noakes, E. J., Storch, N. A., Mellers, A. P., & Lyons, L. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012091 · Cited by 7
Irregular Sleep-Wake Rhythm Disorder
Oyegbile, T. O., & Videnović, A. (2019) · Neurologic Clinics · doi:10.1016/j.ncl.2019.04.002 · Cited by 9
Beyond phase shifting: targeting circadian amplitude for light interventions in humans
Walch, O., Tavella, F., Zeitzer, J. M., & Lok, R. (2024) · SLEEP · doi:10.1093/sleep/zsae247 · Cited by 7
Ryan, R. C., Leslie, M. N., He, P., Young, P. M., Hoyos, C. M., Ong, H. X., & Traini, D. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115575 · Cited by 9
ENLITE PD - A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson’s Disease
Videnovic, A., Coffey, C. S., Klerman, E. B., Cudkowicz, M., Cho, H., Amara, A., Marder, K. S., Zee, P., Desir, C., Ernst, H., et al. (2025) · Movement Disorders · doi:10.1002/mds.70009 · Cited by 7
Self-citationVacca, S., Suri, J. S., & Saba, L. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2292958 · Cited by 8
Ukraintseva, Y. V., & Kovalzon, V. M. (2016) · Human Physiology · doi:10.1134/s0362119716050170 · Cited by 7
Parkinson’s Disease and Sleep/Wake Disturbances
Swick, T. J., & Ondo, W. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-46437-4_7 · Cited by 7
Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise
Luthra, N., Christou, D. D., Clow, A., & Corcos, D. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1228444 · Cited by 7
The Central Clock in Patients With Parkinson Disease—Reply
Videnović, A., Breen, D. P., Barker, R. A., & Zee, P. C. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2711 · Cited by 7
Self-citationExogenous melatonin for Parkinson’s disease: ‘Waking up’ to the need for further trials
Breen, D. P., & Barker, R. A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.012 · Cited by 7
Epigenetic events influencing the biological clock: Panacea for neurodegeneration
Laxmi, I. P. L., & Tamizhselvi, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38836 · Cited by 8
Seasonality as a risk factor for deaths in Parkinson's disease
Fonseca, M. C. M., Sansone, D., Farah, D., FIORINI, A. C., Scorza, C. A., & Scorza, F. A. (2024) · Clinics · doi:10.1016/j.clinsp.2024.100506 · Cited by 7
Schindler, K. A., Torices, S., Schurhoff, N. A., Gallo, D. I., & Toborek, M. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115645 · Cited by 8
Bhaskar, R., Narayanan, K. B., Singh, D. K. K., & Han, S. S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050381989250626071304 · Cited by 7
Sleep in neurodegenerative diseases: A focus on melatonin, melanin‐concentrating hormone and orexin
Guillot, S. J., Luppi, P., Dupuis, L., & Bolborea, M. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70085 · Cited by 6
Wyman, B. T., Adams, D. J., Hendrix, S. B., Groves, J., Croft, W., Ellison, N., Olanow, C. W., & Kieburtz, K. D. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00728 · Cited by 6
Jiang, G., Yuan, L., Liu, X., Wu, H., Yu, H., Zhang, W., Zhang, S., & Huang, Y. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2024.15 · Cited by 6
Impact of Sleep on Autophagy and Neurodegenerative Disease: Sleeping Your Mind Clear
Deutsch, S., & Malik, B. R. (2022) · Archives of Molecular Biology and Genetics · doi:10.33696/genetics.1.007 · Cited by 5
Evaluating the Genetic Role of Circadian Clock Genes in Parkinson’s Disease
Xiang, Y., Huang, J., Wang, Y., Huang, X., Zeng, Q., Li, L., Zhao, Y., Pan, H., Xu, Q., Liu, Z., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03243-9 · Cited by 6
Qamar, M. A., Tall, P., van Wamelen, D. J., Wan, Y.-M., Rukavina, K., Fieldwalker, A., Matthew, D., Leta, V., Bannister, K., & Chaudhuri, К. R. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.08.012 · Cited by 8
Evaluating and managing sleep disorders in the parkinson’s disease clinic
Gulyani, S., Salas, R. M. E., Mari, Z. K., Choi, S. I., Mahajan, A., & Gamaldo, C. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.05.001 · Cited by 6
Heterogeneity of excessive daytime sleepiness in Parkinson’s disease
Babkina, O. V., Poluektov, M. G., & Levin, O. S. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20161166260-70 · Cited by 6
Clinical Use of Melatonin in the Treatment of Sleep Disorders
Zakharov, A. V., & Khivintseva, E. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92656 · Cited by 7
Circadian clock disruption and neuroinflammation in Parkinson's disease: a new perspective
Lauretti, E., & Praticò, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00022-9 · Cited by 6
Onaolapo, O. J., & Onaolapo, A. Y. (2018) · Sleep and Hypnosis · doi:10.5350/sleep.hypn.2019.21.0175 · Cited by 6
Pan, W., Liu, J., Chen, X., Wang, Q., Wu, Y., Bai, Y., Liu, Y., Li, W., Li, W., Yuan, C., et al. (2015) · Integrative Medicine International · doi:10.1159/000435813 · Cited by 5
Badran, A., Khelifa, H., & Gbreel, M. I. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08221-8 · Cited by 5
Ness-Cohn, E., & Braun, R. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab476 · Cited by 5
Therapeutic Effects of Ashwagandha in Brain Aging and Clock Dysfunction
Jagota, A., & Kukkemane, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_21 · Cited by 5
Labunets, I. F. (2017) · Gerontology & Geriatrics Studies · doi:10.31031/ggs.2017.01.000506 · Cited by 5
Mithani, S., & Fink, A. M. (2018) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0000000000000408 · Cited by 5
Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease
Nodel, M. R., Викторовна, Ш. К., Kovrov, G. V., & Yakhno, N. N. (2018) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2018-4-23-29 · Cited by 5
Pathophysiology and pharmacological management for sleep problems in Parkinson's disease
Falup‐Pecurariu, C., Ungureanu, L., Murășan, I., & Diaconu, Ș. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251371945 · Cited by 4
Efficacy of Yokukansankachimpihange on sleep disturbance in Parkinson's disease
Jang, J.-H., Lee, J. A., Jung, I. C., & Yoo, H.-R. (2018) · Medicine · doi:10.1097/md.0000000000011298 · Cited by 4
Güler, S., Çaylan, A., Turan, N., & Dağdeviren, N. (2021) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27486 · Cited by 7
Bugalho, P., Meira, B., & Magriço, M. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105891 · Cited by 4
Георгиевна, К. С., Radionov, D. S., Игоревна, Ш. Н., Kotsyubinskaya, Y. V., Yarygina, Y. V., Андреевна, Б. А., Сивакова, Н. А., Андреевна, С. Д., Yakunina, O. N., Andrianova, A. E., et al. (2024) · Consortium Psychiatricum · doi:10.17816/cp15560 · Cited by 5
Irregular sleep–wake rhythm disorder: From the pathophysiologic perspective to the treatment
Videnović, A., & Cai, A. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90918-1.00006-x · Cited by 4
A review of symptom, pathogenesis and treatment characteristics of the elderly with chronic insomnia
Xia, L., Liu, H., & Ren, J. (2025) · Medicine · doi:10.1097/md.0000000000041346 · Cited by 6
Alterations in sleep-activity cycles and clock gene expression across the synucleinopathy spectrum
Comas, M., Vidal, X., Rawashdeh, O., Grunstein, R. R., Lewis, S. J. G., & Matar, E. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00492-7 · Cited by 5
Rasagiline, sleep quality and well-being in Parkinson’s disease: a pilot study
Mutti, C., Sarnataro, R. B., Beretta, J., Poli, E., Negrotti, A., Rausa, F., Pizzarotti, S., & Parrino, L. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06008-9 · Cited by 4
The use of melatonin for treating sleep disorders in patients with Parkinson's disease
Srinivasan, V., Dominico, D. B., Partonen, T., Othman, Z., & Zakaria, R. (2014) · ChronoPhysiology and Therapy · doi:10.2147/cpt.s44802 · Cited by 4
Lu, S., & Shaffery, J. P. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000255 · Cited by 4
Uysal, H. A., Tiftikçioğlu, B. İ., Öcek, L., & Zorlu, Y. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2017.19367 · Cited by 4
Pharmakotherapie von Schlaf-Wach-Störungen
Holst, S. C., Werth, E., & Landolt, H. (2019) · Praxis · doi:10.1024/1661-8157/a003189 · Cited by 4
Suram, R. P., Fatima, R., Madhuvilakku, R., Jung, J. H., Kim, S. J., & Hong, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1637881 · Cited by 3
Detecting isolated REM sleep behavior disorder at home using a lower-back wearable sensor
TZFONI, T., Tauman, R., Hausdorff, J. M., Hanein, Y., & Mirelman, A. (2026) · npj Digital Medicine · doi:10.1038/s41746-026-02412-z · Cited by 3
Björk, V. (2021) · Rejuvenation Research · doi:10.1089/rej.2020.2388 · Cited by 3
Yalçın, M., Peralta, A. R., Bentes, C. C., Silva, C., Guerreiro, T., Ferreira, J. J., & Relógio, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305712 · Cited by 3
Possibilities of non-drug treatment for Parkinson’s disease
Похабов, Д. В., Абрамов, В. Г., & Похабов, Д. Д. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20161168122-29 · Cited by 3
Chahine, L. M. (2020) · Disorders of Sleep and Wakefulness in Parkinson's Disease · doi:10.1016/b978-0-323-67374-7.00012-2
Sleep: what the day owes the night
Arnulf, I. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70234-0 · Cited by 3
Sleep Quality and Cognitive Impairment in Patients with Parkinson’s Disease in Iran
Sahebzadeh, N., Baf, M. M. F., & Homam, S. M. (2016) · Turkish Journal Of Neurology · doi:10.4274/tnd.84755 · Cited by 3
Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00001-0 · Cited by 4
BMAL1 in Astrocytes: A Protective Role in Alzheimer’s and Parkinson’s Disease
Brash-Arias, D., García, L. I., Aranda-Abreu, G. E., Toledo‐Cárdenas, M. R., Pérez-Estudillo, C. A., & Chi-Castañeda, D. (2025) · Neuroglia · doi:10.3390/neuroglia6010001 · Cited by 2
Psychometric properties of the Epworth Sleepiness Scale in Brazilian medical students
da Silva, R. C. D., Garcêz, A., Brugnoli, A. V. M., Pattussi, M. P., & Olinto, M. T. A. (2025) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0045-1804921 · Cited by 2
Excessive Daytime Sleepiness in Parkinson’s Disease and Parkinsonism
Murășan, I., Diaconu, Ș., Bougea, A. M., & Falup‐Pecurariu, C. (2025) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2025.06.002 · Cited by 2
Loss of Nocturnin increases neuronal viability in oxidative stress conditions
Ojo, A. E., Olivas-Rasmussen, C., Pappas, S. S., & Green, C. B. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1632251 · Cited by 2
Pineal gland senescence: an emerging ageing-related pathology?
Short, E. L., Ajjan, R., Barber, T. M., Bhandari, S., Chazot, P. L., Garrison, J. L., Goyal, A., Huckstepp, R. T. R., Jamal, N., Kanamarlapudi, V., et al. (2025) · HORMONES · doi:10.1007/s42000-025-00720-9 · Cited by 2
Carpi, M., & Liguori, C. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1727683 · Cited by 2
The Role of Cold-Inducible RNA-Binding Protein (CIRP) in Neurological Disorders
Lai, X., & Zhong, P. (2026) · Brain Sciences · doi:10.3390/brainsci16020205 · Cited by 2
Exercise as Chronotherapy: Regulating Circadian Rhythms to Alleviate Symptoms in Parkinson’s Disease
Li, J., Liu, T., & Wei, J. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00844 · Cited by 2
Maidh, A., Kalra, P., Khan, H., Silakari, P., & Grewal, A. K. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01813-z · Cited by 2
Metadata
- Authors
- Videnovic, A., Noble, C., Reid, K. J., Peng, J., Turek, F. W., Marconi, A., Rademaker, A. W., Simuni, T., Zadikoff, C., & Zee, P. C.
- Affiliations
- Neurological Clinical Research Institute, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts2Department of Neurology, Northwestern University, Chicago, Illinois
- Northwestern University (US)
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2014-04-01
- Volume
- 71
- Issue
- 4
- Pages
- 463
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC4078989
- OpenAlex
- W1980509662
- Cited by
- 390
- References
- 51
- Citations by year
- 2026: 22 · 2025: 46 · 2024: 33 · 2023: 29 · 2022: 41 · 2021: 43 · 2020: 31 · 2019: 28 · 2018: 27 · 2017: 34 · 2016: 33 · 2015: 11 · 2014: 12
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000150)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020216)
- National Institute on Aging (P01-AG11412., P01AG011412)
- National Heart, Lung, and Blood Institute (R01HL090873, R01HL105549, UM1HL112856)
- National Institute of Neurological Disorders and Stroke (K23NS072283, U10NS053377, U01NS050324, U01NS050095)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- excessive daytime sleepiness, melatonin rhythm, circadian dysfunction, sleep-wake disturbances, sleep quality, melatonin secretion, non-motor symptoms, circadian phase, dopaminergic therapy, phototherapy, exercise therapy, melatonin supplementation, melatonin receptor agonists
- MeSH terms
- Aged, Circadian Rhythm, Cross-Sectional Studies, Female, Humans, Disorders of Excessive Somnolence, Male, Melatonin, Middle Aged, Parkinson Disease, Registries, Severity of Illness Index, Cohort Studies, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review